Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04329832 · ClinicalTrials.gov registry record · Phase 2

Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19

A Phase 2 study of COVID-19, sponsored by Intermountain Health Care.

Completed
Registry status
Phase 2
Development phase
85
Enrollment target
2
Study locations

NCT04329832 is a Phase 2 study of COVID-19 that has completed, run by Intermountain Health Care. The registered enrollment target is 85 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04329832, a Phase 2 study of COVID-19, has completed, sponsored by Intermountain Health Care.

COMPLETED
Registry status
Phase 2
Development phase
85 participants
Enrollment target
2
Study locations

Study Summary

This study will compare two drugs (hydroxychloroquine and azithromycin) to see if hydroxychloroquine is better than azithromycin in treating hospitalized patients with suspected or confirmed COVID-19.

Conditions Studied

COVID-19

Interventions

  • DRUG Azithromycin
  • DRUG Hydroxychloroquine

Study Locations (2)

Utah

  • Intermountain Medical Center - Murray
  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2020-03-30
Est. Completion 2021-01-01
Phase Phase 2

Sponsor

Intermountain Health Care

85 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04329832

The ClinicalTrials.gov registry entry for NCT04329832 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Azithromycin is the first listed.

NCT04329832 reports 2 study locations spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT04329832 about?

NCT04329832 is a clinical study titled "Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19". This study will compare two drugs (hydroxychloroquine and azithromycin) to see if hydroxychloroquine is better than azithromycin in treating hospitalized patients with suspected or confirmed COVID-19.

What is the current status of trial NCT04329832?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 85 participants. The study started on 2020-03-30. Estimated completion is 2021-01-01.

What conditions does trial NCT04329832 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT04329832?

The interventions under investigation include: Azithromycin (DRUG), Hydroxychloroquine (DRUG).

Who is sponsoring clinical trial NCT04329832?

This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04329832 being conducted?

This trial has 2 study locations across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

COVID-19

All registered trials for this condition

Utah

All trials with a study site in Utah

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.